Position in PFE
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$11,044,075
-$2,695,328 QoQ
Shares Held
458,641
-6.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#396
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CLIFFORD SWAN INVESTMENT COUNSEL LLC holds $170,286,954 across 10 Drug Manufacturers - General names. PFE ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
207,571 | $52,716,806 | |
| 2 | ABBV |
AbbVie Inc.
|
145,173 | $36,531,333 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
293,833 | $16,930,657 | |
| 4 | NVO |
Novo Nordisk A S
|
318,484 | $15,268,122 | |
| 5 | AMGN |
Amgen Inc
|
36,058 | $13,057,322 | |
| 6 | PFE |
Pfizer Inc
This page
|
458,641 | $11,044,075 | |
| 7 | MRK |
Merck & Co., Inc.
|
75,680 | $9,724,880 | |
| 8 | NVS |
Novartis AG
|
60,118 | $9,421,692 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,044,075 | 458,641 | Shares | Other | 2026-08-20 | |
| 2026-03-31 | $13,739,403 | 489,295 | Shares | Other | 2026-05-06 | |
| 2025-12-31 | $12,090,194 | 485,550 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $12,809,152 | 502,714 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $13,796,728 | 569,172 | Shares | Other | 2025-07-30 | |
| 2025-03-31 | $15,121,492 | 596,744 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $15,961,084 | 601,624 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $16,042,744 | 554,345 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,543,724 | 519,790 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $14,342,726 | 516,855 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $12,007,445 | 417,070 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $13,216,885 | 398,459 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $14,579,456 | 397,477 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $16,299,396 | 399,495 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $20,802,927 | 405,990 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $17,794,391 | 406,636 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $21,637,913 | 412,701 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $21,757,274 | 420,268 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $24,787,772 | 419,776 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $18,113,833 | 421,154 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $17,402,821 | 444,403 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $17,059,438 | 470,865 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $16,344,891 | 444,034 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $16,709,787 | 455,308 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $15,017,294 | 459,244 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $15,184,433 | 465,210 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||